has role voriconazole Drug_Central:2846 CHEBI:10023 CHEBI:127308 PMID:23392902 LINCS:LSM-5244 PMID:24102553 A triazole-based antifungal agent used for the treatment of esophageal candidiasis, invasive pulmonary aspergillosis, and serious fungal infections caused by Scedosporium apiospermum and Fusarium spp. It is an inhibitor of cytochrome P450 2C9 (CYP2C9) and CYP3A4. chebi_ontology (R-(R*,S*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol KEGG:D00578 Patent:US5278175 PMID:23527908 voriconazole DrugBank:DB00582 KEGG:C07622 PMID:22718362 PMID:23766489 Wikipedia:Voriconazole VCZ CAS:137234-62-9 (alphaR,betaS)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol Patent:EP440372 PMID:12940129 Beilstein:7694998 tertiary alcohol difluorobenzene pyrimidines P450 inhibitor conazole antifungal drug triazole antifungal drug